-
Je něco špatně v tomto záznamu ?
Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy
D. Sánchez, P. Gregor, K. Čurila, I. Hoffmanová, V. Hábová, L. Tučková, H. Tlaskalová-Hogenová,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Medline Complete (EBSCOhost)
od 2002-02-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- autoantigeny krev imunologie MeSH
- autoimunita MeSH
- autoprotilátky krev imunologie MeSH
- biologické markery MeSH
- dilatační kardiomyopatie krev diagnóza imunologie MeSH
- dospělí MeSH
- ELISA MeSH
- hypertrofická kardiomyopatie krev diagnóza imunologie MeSH
- imunoglobulin A krev imunologie MeSH
- imunoglobulin G krev imunologie MeSH
- kalretikulin krev imunologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Distinct cellular level of the Ca2+-binding chaperone calreticulin (CRT) is essential for correct embryonal cardiac development and postnatal function. However, CRT is also a potential autoantigen eliciting formation of antibodies (Ab), whose role is not yet clarified. Immunization with CRT leads to cardiac injury, while overexpression of CRT in cardiomyocytes induces dilated cardiomyopathy (DCM) in animals. Hence, we analysed levels of anti-CRT Ab and calreticulin in the sera of patients with idiopatic DCM and hypertrophic cardiomyopathy (HCM). ELISA and immunoblot using human recombinant CRT and Pepscan with synthetic, overlapping decapeptides of CRT were used to detect anti-CRT Ab. Serum CRT concentration was tested by ELISA. Significantly increased levels of anti-CRT Ab of isotypes IgA (p < 0.001) and IgG (p < 0.05) were found in patients with both DCM (12/34 seropositive for IgA, 7/34 for IgG) and HCM (13/38 seropositive for IgA, 11/38 for IgG) against healthy controls (2/79 for IgA, 1/79 for IgG). Titration analysis in seropositive DCM and HCM patients documented anti-CRT Ab detected at 1/1600 dilution for IgG and 1/800 for IgA (and IgA1) and at least at 1/200 dilution for IgA2, IgG1, IgG2 and IgG3. Pepscan identified immunogenic CRT epitopes recognized by IgA and IgG Ab of these patients. Significantly increased levels of CRT relative to healthy controls were found in sera of patients with HCM (p < 0.01, 5/19). These data extend the knowledge of seroprevalence of anti-CRT Ab and CRT, and suggest possible involvement of autoimmune mechanisms directed to CRT in some forms of cardiomyopathies, which are clinically heterogeneous.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017015
- 003
- CZ-PrNML
- 005
- 20180515103325.0
- 007
- ta
- 008
- 180515s2016 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/08916934.2016.1214822 $2 doi
- 035 __
- $a (PubMed)27689957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Sánchez, Daniel $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
- 245 10
- $a Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy / $c D. Sánchez, P. Gregor, K. Čurila, I. Hoffmanová, V. Hábová, L. Tučková, H. Tlaskalová-Hogenová,
- 520 9_
- $a Distinct cellular level of the Ca2+-binding chaperone calreticulin (CRT) is essential for correct embryonal cardiac development and postnatal function. However, CRT is also a potential autoantigen eliciting formation of antibodies (Ab), whose role is not yet clarified. Immunization with CRT leads to cardiac injury, while overexpression of CRT in cardiomyocytes induces dilated cardiomyopathy (DCM) in animals. Hence, we analysed levels of anti-CRT Ab and calreticulin in the sera of patients with idiopatic DCM and hypertrophic cardiomyopathy (HCM). ELISA and immunoblot using human recombinant CRT and Pepscan with synthetic, overlapping decapeptides of CRT were used to detect anti-CRT Ab. Serum CRT concentration was tested by ELISA. Significantly increased levels of anti-CRT Ab of isotypes IgA (p < 0.001) and IgG (p < 0.05) were found in patients with both DCM (12/34 seropositive for IgA, 7/34 for IgG) and HCM (13/38 seropositive for IgA, 11/38 for IgG) against healthy controls (2/79 for IgA, 1/79 for IgG). Titration analysis in seropositive DCM and HCM patients documented anti-CRT Ab detected at 1/1600 dilution for IgG and 1/800 for IgA (and IgA1) and at least at 1/200 dilution for IgA2, IgG1, IgG2 and IgG3. Pepscan identified immunogenic CRT epitopes recognized by IgA and IgG Ab of these patients. Significantly increased levels of CRT relative to healthy controls were found in sera of patients with HCM (p < 0.01, 5/19). These data extend the knowledge of seroprevalence of anti-CRT Ab and CRT, and suggest possible involvement of autoimmune mechanisms directed to CRT in some forms of cardiomyopathies, which are clinically heterogeneous.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a autoprotilátky $x krev $x imunologie $7 D001323
- 650 _2
- $a autoantigeny $x krev $x imunologie $7 D001324
- 650 _2
- $a autoimunita $7 D015551
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kalretikulin $x krev $x imunologie $7 D037282
- 650 _2
- $a dilatační kardiomyopatie $x krev $x diagnóza $x imunologie $7 D002311
- 650 _2
- $a hypertrofická kardiomyopatie $x krev $x diagnóza $x imunologie $7 D002312
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobulin A $x krev $x imunologie $7 D007070
- 650 _2
- $a imunoglobulin G $x krev $x imunologie $7 D007074
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gregor, Pavel $u b Cardiocenter, Department of Cardiology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic , and.
- 700 1_
- $a Čurila, Karol $u b Cardiocenter, Department of Cardiology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic , and.
- 700 1_
- $a Hoffmanová, Iva $u c Second Department of Internal Medicine, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic.
- 700 1_
- $a Hábová, Věra $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
- 700 1_
- $a Tučková, Ludmila $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
- 700 1_
- $a Tlaskalová-Hogenová, Helena $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
- 773 0_
- $w MED00000637 $t Autoimmunity $x 1607-842X $g Roč. 49, č. 8 (2016), s. 554-562
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27689957 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103458 $b ABA008
- 999 __
- $a ok $b bmc $g 1300639 $s 1013855
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 49 $c 8 $d 554-562 $e 20160930 $i 1607-842X $m Autoimmunity $n Autoimmunity $x MED00000637
- LZP __
- $a Pubmed-20180515